The pharmaceutical companies hate it. The Biden administration is embracing it. Now, finding common ground for wider distribution of Covid-19 vaccines in poorer countries falls to the World Trade Organization -- a body known more for its inability to do international deals than to clinch them.
Merck & Co. Inc. and Glenmark Pharmaceuticals Inc. argued Thursday that the Fourth Circuit should reverse a decision granting class status to wholesalers alleging the manufacturers entered into an anti-competitive agreement to delay entry of generic competition to the cholesterol drug Zetia.
The success of an international waiver of patent protections on Covid-19 vaccines largely hangs on whether the U.S. forces its companies to share manufacturing specifications and may not be the harbinger of global immunization it’s cracked up to be, critics say.